Jaguar Animal Health News and Activities

Jaguar Animal Health is a company listed under the stock ticker JAGX (US).

Jaguar Animal Health has a direct presence in 2 countries.

They are in:

• Healthcare67%
• Pharmaceuticals33%

View the org chart displaying its 24 main executives

Most searched biographies at Jaguar Animal Health

• Lisa Conte, Chief Executive Officer, Executive Director
• Jonathan Siegel, Director
• James Bochnowski, Chairman of the Board

Create your alert
to follow the executive moves at Jaguar Animal Health.

Jaguar Animal Health has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Corden Pharma has announced the acquisition of AmbioPharm  (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Jonathan Leff - Director at Larimar Therapeutics
• Richard Saynor - Chief Executive Officer at Sandoz

Learn more about the Pharmaceuticals industry

Press releases by Jaguar Animal Health

• Jaguar Health Appoints Senior Healthcare and Investment Executive Dr. Anula Jayasuriya to Board of Directors and Forms Business Development Advisory Committee to Assess Opportunities for Alliances, Mergers, and Acquisitions | Jaguar Health, Inc.
• Jaguar Health Enters Exclusive Crofelemer License and Commercialization Agreement with SynWorld Technologies for Canalevia for Treatment of Diarrhea in Dogs in China | Jaguar Health, Inc.
• Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Jaguar Health, Inc.
• Jaguar Health Announces Online Availability of a Presentation on Short Bowel Syndrome (SBS) by Dr. Mohamad Miqdady at Elite Ped-GI Congress in Abu Dhabi | Jaguar Health, Inc.
• Jaguar Animal Health Exhibiting at the June 23-25 American College of Veterinary Internal Medicine (ACVIM) Forum as Part of Ongoing Commercial Launch Activities for Canalevia-CA1 | Jaguar Health, Inc.
• Jaguar Health Announces Publication of Onco'Zine Article Underscoring the Importance of Controlling Diarrhea in Cancer Patients | Jaguar Health, Inc.
• Jaguar Health Reports Voting Results from 2022 Annual Meeting of Stockholders | Jaguar Health, Inc.
• Jaguar Health to Participate in BIO International Convention (BIO 2022) | Jaguar Health, Inc.
• Jaguar Health and Filament Health Sign Letter of Intent to Develop Botanical Prescription Drugs for Specific Mental Health Indications | Jaguar Health, Inc.
• Jaguar Health Announces Napo Therapeutics' Submission of Orphan Drug Designation Application to the European Medicines Agency for Crofelemer for a Severe Congenital Diarrheal Disorder (CDD) Condition | Jaguar Health, Inc.
• View more press releases Close

Social media about Jaguar Animal Health

• Jaguar Animal Health on Wikipedia, Google News & Yahoo Finance
• Jaguar Animal Health on LinkedIn, X (Twitter) & YouTube